Drug Elimination
Drug Elimination - Related Videos
01:17
Kinetics of Drug Elimination
0 Views •
2023
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes. Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
01:18
Drug Elimination: Overview
0 Views •
2025
Drug elimination involves many complex processes and does not necessarily differentiate between distribution and elimination. It is divided into two primary components: excretion and biotransformation. Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
01:23
Drug Elimination: Non-Renal Routes
0 Views •
2023
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
01:06
Drug Elimination: The Concept of Clearance
0 Views •
2023
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug. Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
01:22
Drug Elimination by Renal Route: Tubular Reabsorption
0 Views •
2023
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
FAQs
Clearance, elimination rate, and half-life provide complementary measures of how drug concentrations change over time. Clearance supports estimation of the body’s capacity to remove a drug, while elimination rate describes removal over time and half-life helps indicate persistence. Pharmacologists use these measures together to anticipate concentration profiles and design dosing intervals that maintain appropriate effects.
These routes remove substances through different biological steps. Hepatic metabolism chemically converts many compounds into more water-soluble metabolites, whereas renal excretion handles substances through filtration, secretion, and sometimes reabsorption in the nephron. Comparing the routes helps pharmacologists understand why a drug or its metabolites may persist for different lengths of time.
Renal elimination is not limited to filtration and secretion because the nephron may reabsorb substances after they enter the renal pathway. Reabsorption can therefore alter how much drug or metabolite ultimately leaves the body. Accounting for filtration, secretion, and reabsorption gives a more complete interpretation of renal handling when pharmacologists evaluate concentration changes.
Changes in liver or kidney function can alter how long pharmacological effects persist because these organs contribute major routes of removal. Pharmacologists therefore consider organ status when interpreting elimination measures and selecting therapy. This context is especially important for dose selection and dosing-interval design, since altered removal may change drug concentrations over time.
Pharmacologists examine elimination rate, clearance, and half-life to relate drug removal to concentration changes over time. They use this information to select an appropriate dose and determine how frequently it should be administered. The same analysis supports later adjustment when liver or kidney function changes, helping align treatment with the patient’s expected elimination pattern.
Biliary and pulmonary routes matter when a drug or metabolite is not described by hepatic metabolism and renal excretion alone. The overview identifies both as contributing pathways, so pharmacologists can include them when interpreting overall removal. Considering these routes broadens assessment of elimination and may help explain concentration or effect patterns that the main routes do not fully describe.